Australia markets open in 2 hours 43 minutes

Acasti Pharma Inc. (ACST)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.4580-0.0077 (-1.65%)
At close: 4:00PM EDT
0.4600 0.00 (0.44%)
After hours: 05:11PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.4657
Open0.4671
Bid0.4600 x 1100
Ask0.4679 x 1000
Day's range0.4502 - 0.4799
52-week range0.1700 - 1.2200
Volume2,816,098
Avg. volume13,475,746
Market cap96.001M
Beta (5Y monthly)1.50
PE ratio (TTM)N/A
EPS (TTM)-0.1660
Earnings date11 Aug 2021 - 16 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.52
  • Reminder: Acasti Pharma to Host Conference Call on August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics
    GlobeNewswire

    Reminder: Acasti Pharma to Host Conference Call on August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics

    LAVAL, Québec, July 29, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) announces a reminder that it will host a business update conference call on Wednesday, August 4th at 1:00 PM ET to discuss the planned acquisition of Grace Therapeutics, Inc. (“Grace”), a privately held emerging biopharmaceutical company focused on developing innovative drug delivery technologies for the treatment of rare and orphan diseases, as well as topics related to

  • Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics
    GlobeNewswire

    Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics

    All shareholders are strongly encouraged to vote in advance of the August 26, 2021, annual and special meeting of shareholdersLAVAL, Québec, July 23, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) announces it will host a business update conference call on Wednesday, August 4th at 1:00 PM ET to discuss the planned acquisition of Grace Therapeutics, Inc. (“Grace”), a privately held emerging biopharmaceutical company focused on developing inn

  • INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, SHSP, ICBK, ACST; Shareholders are Encouraged to Contact the Firm
    GlobeNewswire

    INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, SHSP, ICBK, ACST; Shareholders are Encouraged to Contact the Firm

    NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Raven Industries, Inc. (NASDAQ: RAVN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to CNH Industrial N.V. for $58.00 per share. If you are a Raven shareholder, click here to learn more about your rights and options. SharpSpring, Inc. (NASDAQ: SHSP) concerning potential vio